GRIDAI TECHNOLOGIES CORP.

Profile

Company Names

GRIDAI TECHNOLOGIES CORP.
ENTERO THERAPEUTICS, INC.
FIRST WAVE BIOPHARMA, INC.
AZURRX BIOPHARMA, INC.
BIOPHARMA D-AZUR, INC.

Addresses

433 PLAZA REAL, SUITE 275, BOCA RATON, FL 33432

79014TH ST N # 21135, ST. PETERSBURG, FL 33702

777 YAMATO ROAD, SUITE 502, BOCA RATON, FL 33431

777 YAMATO ROAD, SUITE 502, BOCA RATON, FL 33431

760 PARKSIDE AVE., SUITE 304, BROOKLYN, NY 11226

760 PARKSIDE AVENUE, SUITE 304, BROOKLYN, NY 11226

760 PARKSIDE AVENUE, DOWNSTATE BIOTECH. INCUBATOR SUITE 217, BROOKLYN, NY 11226

1410 BROADWAY, 23RD FLOOR, NEW YORK, NY 10018

Phone Numbers

561-589-7020
646-699-7855
(646) 699-7855
917-842-2353

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

2014

State Incorporated:

DELAWARE

Total Amount Raised:

$58,151,484.00

Number of Funding Rounds:

16
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
16
2026-05-11 
$5,250,000.00 
$5,250,000.00 
$0.00 
Equity 
15
2026-05-08 
$2,540,000.00 
$2,540,000.00 
$0.00 
Equity 
14
2025-08-09 
$3,025,000.00 
$3,025,000.00 
$0.00 
 
13
2023-09-14 
$1,470,509.00 
$1,470,509.00 
$0.00 
 
12
2023-06-13 
$431,083.00 
$431,083.00 
$0.00 
 
11
2023-03-15 
$4,000,001.00 
$4,000,001.00 
$0.00 
Equity 
10
2022-11-22 
$2,500,001.00 
$2,500,001.00 
$0.00 
Equity 
9
2022-07-15 
$300,000.00 
$300,000.00 
$0.00 
Equity 
8
2020-07-16 
$22,426,890.00 
$22,800,000.00 
$373,110.00 
Equity 
7
2019-12-20 
$6,904,000.00 
$8,000,000.00 
$1,096,000.00 
Debt 
6
2019-02-14 
$2,000,000.00 
$2,000,000.00 
$0.00 
Debt 
5
2017-06-05 
$5,000,000.00 
$5,000,000.00 
$0.00 
Equity 
4
2017-04-09 
$1,000,000.00 
$1,000,000.00 
$0.00 
Debt 
3
2016-03-30 
$635,000.00 
$12,000,000.00 
$11,365,000.00 
Debt 
2
2014-10-14 
$284,000.00 
$7,000,000.00 
$6,716,000.00 
Debt 
1
2014-03-25 
$385,000.00 
$1,020,250.00 
$635,250.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MATTHEW 
 
BALK 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
ED 
 
BORKOWSKI 
DIRECTOR
EDWARD 
 
BORKOWSKI 
DIRECTOR
EDWARD 
M. 
BORKOWSKI 
DIRECTOR
CHARLES 
M. 
CASAMENTO 
DIRECTOR
TERRY 
 
COELHO 
DIRECTOR
ERIC 
 
CORBETT 
DIRECTOR
DANIEL 
 
DUPRET 
EXECUTIVE OFFICER
GREGORY 
 
OAKES 
DIRECTOR
RICHARD 
 
PAOLONE 
EXECUTIVE OFFICER, DIRECTOR
JAMES 
 
PENNINGTON 
EXECUTIVE OFFICER
JAMES 
LEE 
PENNINGTON 
EXECUTIVE OFFICER
GEORDAN 
 
PURSGLOVE 
DIRECTOR
ALASTAIR 
 
RIDDELL 
DIRECTOR
ALASTAIR 
M. 
RIDDELL 
DIRECTOR
CHRISTINE 
 
RIGBY 
EXECUTIVE OFFICER
SARAH 
 
ROMANO 
EXECUTIVE OFFICER
JAMES 
 
SAPIRSTEIN 
EXECUTIVE OFFICER, DIRECTOR
JASON 
 
SAWYER 
DIRECTOR, EXECUTIVE OFFICER
DANIEL 
 
SCHNEIDERMAN 
EXECUTIVE OFFICER
VERN 
 
SCHRAMM 
DIRECTOR
VERN 
LEE 
SCHRAMM 
DIRECTOR
MAGED 
 
SHENOUDA 
DIRECTOR, EXECUTIVE OFFICER
MAGED 
M. 
SHENOUDA 
DIRECTOR
ANNA 
 
SKOWRON 
EXECUTIVE OFFICER
JOHAN 
 
SPOOR 
EXECUTIVE OFFICER, DIRECTOR
JOHAN 
M. 
SPOOR 
EXECUTIVE OFFICER, DIRECTOR
JOHAN (THIJS) 
 
SPOOR 
DIRECTOR, EXECUTIVE OFFICER
MANPREET 
 
UPPAL 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2026-05-11 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2026-05-08 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2025-08-09 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2023-09-14 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2023-06-13 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-03-15 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-11-22 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-07-15 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-07-16 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Debt 
2019-12-20 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Debt 
2019-02-14 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-06-05 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Debt 
2017-04-09 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2016-03-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2014-10-14 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-03-25 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
ROTH CAPITAL PARTNERS, LLC
NONE
NONE
H.C. WAINWRIGHT + CO. LLC
375
NONE
NONE
ALEXANDER CAPITAL, L.P.
NONE
NONE
ALEXANDER CAPITAL, L. P.
NONE
NONE
ALEXANDER CAPITAL, LP